
Luigi Mangione's attorneys say prosecutors wrongfully obtained his medical records
In a letter filed Thursday, attorneys for Mangione said the Manhattan District Attorney's Office obtained over 120 pages of information from Aetna, including information about 'different diagnoses as well as specific medical complaints made by Mr. Mangione' without the court or defense team's knowledge.
The prosecution improperly compelled Aetna to turn over Mangione's medical records directly to its office without facilitation from the court, according to the defense letter.
'The District Attorney falsely made up a court date - May 23, 2025 - and drafted a fraudulent subpoena that if Aetna did not provide documents on that date, it would be in contempt of Court,' the letter says. 'Then, rather than having Aetna give the documents to the Court, as required by the already fraudulent subpoena, the District Attorney told Aetna to provide the documents directly to the District Attorney, intentionally eliminating the Court from the subpoena process and ensuring that the District Attorney would secure these confidential medical records.'
Mangione's defense also argues the information prosecutors obtained from Aetna isn't relevant to the state's criminal case.
'As defense counsel knows, the people requested very limited information from Aetna and Aetna sent us additional materials in error,' a spokesperson for the district attorney's office told CNN. 'We deleted the materials as soon as we became aware of them and brought it to defense and the court's attention.' The DA's office said it will respond further in a court filing.
The defense has asked the court to hold an evidentiary hearing and for access to all communications between Aetna and the District Attorney's Office.
'Aetna received a subpoena for certain medical records, and we provided them appropriately,' an Aetna spokesperson told CNN.
Mangione faces the death penalty in federal court where he's indicted for murder and other charges related to the death of UnitedHealthcare CEO Brian Thompson.
He has pleaded not guilty to all federal and state charges against him.
The shooting in New York City and subsequent dayslong manhunt that ended in Pennsylvania captured national attention as investigators shared details of Mangione's alleged writings and the words 'delay,' 'deny' and 'depose' written on bullets found at the scene.
Diary entries written by Mangione reveal the 27-year-old's detailed thinking before the killing, according to a previous court filing.
In August 2024, roughly four months before he allegedly shot and killed Thompson in midtown Manhattan, Mangione wrote in his diary: 'I finally feel confident about what I will do. The details are coming together. And I don't feel any doubt about whether it's right/justified. I'm glad-in a way-that I've procrastinated bc it allowed me to learn more about (UnitedHealthcare).'
'The target is insurance. It checks every box,' he continued in the August 15 entry.
Mangione allegedly gunned down Thompson on a busy sidewalk as Thompson walked toward a hotel hosting his company's investors' conference, authorities said.
He was not insured by UnitedHealthcare from 2014 to 2024, prosecutors say, but at the time of his arrest, Mangione allegedly had a handwritten notebook that expressed 'hostility toward the health insurance industry and wealthy executives in particular,' according to a federal complaint.
In recent years, Mangione suffered from troubling back pain and underwent surgery to treat it, according to a friend, R.J. Martin, and online postings.
Around 2022, Mangione moved to Hawaii, where he lived for about six months at a co-working and co-living space in Honolulu, Martin told CNN in December 2024.
Martin said he fell out of touch with Mangione and last exchanged texts with him earlier last year. Mangione told him that he had undergone back surgery and sent him a photo of his X-ray that, Martin said, 'looked heinous, with just giant screws going into his spine.'
And on the book review website, Goodreads, Mangione reported reading or wanting to read a number of books about coping with chronic back pain. He also linked to handwritten notes laying out his workout routine, which state that he was suffering from spondylolisthesis, the slippage of a vertebrae in the spine.
Posts from a now-deleted Reddit account that does not list Mangione's name but closely matches many of his biographical details – including his university, age, major and health condition – say that the user had suffered from back aches related to spondylolisthesis since childhood but aggravated the condition after a surfing incident.
In 2023 the user wrote that he had undergone spinal surgery, which improved his symptoms. The user did not appear to post about health insurance related to the surgery, or connect the treatment to UnitedHealthcare.
It's unclear if any of the Aetna records turned over to prosecutors were related to a back injury or surgery, but the defense letter said prosecutors at least partially reviewed Mangione's confidential doctor-patient privileged and HIPAA protected medical records.
CNN's Dalia Faheid, Casey Tolan, Blake Ellis, Melanie Hicken, Jeff Winter and Yahya Abou-Ghazala, Eric Levenson and Kara Scannell contributed to this report.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Man convicted in infamous 1979 Etan Patz murder could get new trial
A federal appeals court determined the man convicted in the 1979 disappearance of 6-year-old Etan Patz should get a new trial or be released from custody in the interim. Pedro Hernandez was sentenced in 2017 to 25 years in prison after confessing to kidnapping and killing Patz in New York City, in what is one of the nation's most notorious child disappearance cases. The decision comes in response to Hernandez's appeal, in which he alleges a jury note was improperly handled during his trial and "prejudiced the verdict." In the July 21 decision from the 2nd U.S. Circuit Court of Appeals, the judge said the state trial court contradicted federal law and ordered Hernandez be released, unless the state goes forward with a retrial in what they determine to be a "reasonable period" of time. Patz went missing on his way to a school bus stop in his Soho neighborhood in May 1979. The widely publicized case was a lightning rod for law enforcement practices nationwide, and he was one of the first missing children ever to appear on a milk carton. Hernandez was a clerk at a store in Patz's neighborhood, and became a suspect decades after the first-grader disappeared, in 2012. Renewed interest in what had become a cold case prompted a relative to tell police Hernandez told a prayer group decades earlier that he'd killed a child. Hernandez's first trial in 2015 ended in a hung jury, while his second trial in 2017 ended with a conviction on charges of murder and kidnapping. The case helped establish National Missing Children's Day on May 25th, and for the creation of a national hotline for missing children. Patz's body has never been recovered, and was legally declared dead in 2001. Kathryn Palmer is a national trending news reporter for USA TODAY. You can reach her at kapalmer@ and on X @KathrynPlmr. This article originally appeared on USA TODAY: Etan Patz case: Pedro Hernandez should get new trial, court rules
Yahoo
22 minutes ago
- Yahoo
Analysts Are Cutting Their Price Targets for UnitedHealth Stock Before Q2 Earnings. Is It Time to Ditch Shares?
UnitedHealth (UNH) has not had a healthy time for the better part of the last 12 months. The company has been rocked by the assassination of its CEO Brian Thompson in December 2024, as well as by the questioning of its policy practices, shareholder lawsuits, and Justice Department investigations. UNH shares are now down 44% on a year to date basis. To compound matters further, analysts have been slashing their price target ahead of its second quarter earnings. Morgan Stanley's Erin Wright cut the price target from to $342 from $374 earlier, citing ongoing challenges at UnitedHealth's health services unit, Optum, and Wolfe Research trimmed its price target sharply to $330 from $363, warning about near-term earnings volatility and delayed sentiment recovery around the stock. Meanwhile, Barclays lowered its price target to $337 from $350, highlighting earnings pressure. All retained their 'Buy' or 'Outperform' ratings on the stock, though. More News from Barchart It's Never 'Happened in the History of Tech to Any Company Before': OpenAI's Sam Altman Says ChatGPT is Growing at an Unprecedented Rate This Penny Stock Wants to Become the MicroStrategy of Dogecoin Option Volatility And Earnings Report For July 21 - 25 Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! About UnitedHealth Stock Over the past 20 years, the UNH stock has been a bona fide wealth creator for its shareholders, amassing share price growth of a whopping 450%. The company now operates through two segments, UnitedHealthcare and Optum. While UnitedHealthcare offers health insurance plans, including Medicare Advantage and commercial products, Optum is a fast-growing services arm providing pharmacy benefits, care delivery, analytics, and IT services. Additionally, it is the largest health insurer in the United States and ranked number one globally by revenue in the healthcare industry. So, can UNH finally find its mojo back? I think it can and here's why. UNH Is Too Big to Ignore As highlighted above, UnitedHealth commands a dominant position as the largest health insurer in the United States. That scale gives it real leverage in the market. But perhaps more important is how the company brings together two traditionally separate lines of business. UnitedHealth commands a level of coordination that pure-play insurers can't match, allowing for operational synergies that offer both efficiency and flexibility. In the first quarter of 2025, customer growth in UnitedHealthcare was particularly notable, rising by 780,000 individuals from the previous quarter. The total number now stands at 3.2 million. This uptick appears to be linked to strong uptake in some of the company's more tailored healthcare offerings. The benefits of that growth are evident in the top-line momentum across all key business segments, including Optum Insight and Optum Rx. Delving further into Optum, what makes the business even more interesting is its steady, contract-based revenue. Unlike insurance, which tends to be vulnerable to short-term medical cost volatility, Optum offers stability. At this point, nearly 43% of UnitedHealth's operating income is being generated by its healthcare services division. And management has signaled clear intent to keep expanding this business. In 2025, they are aiming to add another 650,000 patients under value-based care agreements. Broadly, demographic forces remain in UnitedHealth's favor. As the U.S. population ages, the demand for integrated health solutions continues to rise. The company's holistic model is well suited to meet that growing demand. Still, there are concerns. UnitedHealth has been criticized for what some see as an unusually high claims denial rate, and that narrative could hurt its brand image with the possibility of consumers taking their business elsewhere. At the same time, financial ratios show pressure. The company's combined ratio sits at 97.2%, which leaves little room for error. Also, in the first quarter, its medical care ratio came in at 84.8%, a slight increase from 84.3% a year earlier. That movement, though small, is negative for profitability since it indicates that the cost of providing care is rising faster than premiums. Solid Fundamentals UnitedHealth missed both revenue and earnings estimates in the most recent quarter. Still, the company reported revenues of $109.6 billion in Q1, 2025, up $9.8 billion year over year. In terms of segments, Optum's revenues were at $63.9 billion in the quarter, up from $61.1 billion, with an improvement in operating margins to 6.1% from 5.8%, in the year-ago period. Earnings at $7.20 per share grew by 4.2% from the prior year but slightly missed the consensus estimate. Coming to cash flows, in Q1 2025, UNH's cash flow from operations surged to $5.5 billion compared to just $1.1 billion in the prior year as the company closed the quarter with a cash balance of $34.3 billion. This was much higher than its short-term debt of $9.9 billion. However, a reduction in projected 2025 net earnings per share to be between $24.65 to $25.15 per share earlier is a concern. Yet, revenue estimates remained unchanged at $450 billion to $455 billion, the midpoint of which would denote yearly growth of 6.8%. Also, UNH stock is trading at comfortable valuations. Its forward price-earnings ratio of 14.1x is nearly 40% below the sector median. The company will report its Q2 2025 earnings on July 29. Analyst Opinions on UNH Stock Overall, analysts have attributed a rating of 'Moderate Buy' for UnitedHealth stock, with a mean target price of $358.70. This denotes uspide potential of about 27% from current levels. Out of 24 analysts covering the stock, 15 have a 'Strong Buy' rating, two have a 'Moderate Buy' rating, and seven have a 'Hold' rating. On the date of publication, Pathikrit Bose did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
Seven people hospitalized after large truck crashes into Job Corps building in Devens
Seven people were hospitalized and several more injured after a large flatbed truck crashed through the Shriver Job Corps building in Devens. Massachusetts State Police say the truck slammed into the building on the Shriver Job Corps campus on Jackson Road around 10:30 a.m. The driver of the truck and six other people at the site were taken to nearby hospitals. The large truck carrying a red box could be seen buried about halfway into the lobby of a building. Devens Fire Chief Timothy Kelly said six other people were also treated at the scene but did not need to be taken to a hospital. Job Corps is a federally funded education and training school for 16 to 24-year-olds who are in poverty and endured hardships like abuse and homelessness. Some of the injured were young students and worked enrolled in Job Corps, according to Chief Kelly. Massachusetts State Police are investigating the cause of the crash. State police say more info will be released at a later time. This is a developing story. Check back for updates as more information becomes available. Download the FREE Boston 25 News app for breaking news alerts. Follow Boston 25 News on Facebook and Twitter. | Watch Boston 25 News NOW Solve the daily Crossword